Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Autolog stamcellebehandling til patienter med multipel sklerose

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{fbde97c30025450993fdbb0194a46682,
title = "Autolog stamcellebehandling til patienter med multipel sklerose",
abstract = "Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.",
author = "Freja Jespersen and Anne Fischer-Nielsen and Petersen, {S{\o}ren Lykke} and Morten Blinkenberg",
year = "2019",
month = "9",
day = "2",
language = "Dansk",
volume = "181",
pages = "V03190186",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "36",

}

RIS

TY - JOUR

T1 - Autolog stamcellebehandling til patienter med multipel sklerose

AU - Jespersen, Freja

AU - Fischer-Nielsen, Anne

AU - Petersen, Søren Lykke

AU - Blinkenberg, Morten

PY - 2019/9/2

Y1 - 2019/9/2

N2 - Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.

AB - Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.

M3 - Tidsskriftartikel

VL - 181

SP - V03190186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 36

ER -

ID: 58451636